Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer - Sirotnak, FM; She, Y; Lee, F (Clin Cancer Res, 2002)
et al.